Stryker Corporation (SYK) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extrem...
Stryker Corporation's revenue increased 11.2% year over year, from $22.59B to $25.12B.
Net income increased 8.5% over the same period, from $2.99B to $3.25B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 122% in total.
Total debt increased by 16.6% to $15.86B.
The debt-to-equity ratio stands at 0.71, indicating a moderate leverage profile.
Operating cash flow grew 18.9% to $5.04B.
Stryker Corporation maintains a healthy net profit margin of 12.9%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $5.49B+1.3% | $834.0M | $3.52B | $1.08B | $1.47B | $43.83B | $15.48B | $20.15B |
| Q4 FY2024 | $6.44B+17.1% | $546.0M | $4.17B | $581.0M | $1.93B | $42.97B | $13.60B | $20.63B |
| Q1 FY2025 | $5.87B-8.9% | $654.0M | $3.74B | $837.0M | $250.0M | $46.01B | $16.78B | $20.93B |
| Q2 FY2025 | $6.02B+2.7% | $884.0M | $3.84B | $1.11B | $1.11B | $46.33B | $16.58B | $21.19B |
| Q3 FY2025 | $6.06B+0.6% | $859.0M | $3.85B | $1.14B | $1.54B | $47.06B | $16.59B | $21.79B |
| Q4 FY2025 | $7.17B+18.4% | $849.0M | $4.63B | $1.80B | $2.14B | $47.84B | $15.86B | $22.42B |
| Q1 FY2026 | $6.02B-16.1% | $745.0M | $3.81B | $936.0M | $581.0M | $46.29B | $15.23B | $22.98B |
| Q2 FY2026 | $6.59B+9.5% | $1.28B | $4.50B | $1.66B | $1.26B | $47.93B | $15.45B | $23.99B |
Balance Sheet Summary (Q2 FY2026)
Stryker Corporation (SYK) Financial Statements & Revenue History
Stryker Corporation (SYK) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry trading at $295.00 with a market capitalization of $113. This page provides 42 historical financial statements for Stryker Corporation, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Stryker Corporation reported revenue of $25.1 billion, representing 11.2% year-over-year growth. The net profit margin of 12.9% indicates moderate profitability. The debt-to-equity ratio of 0.71 reflects moderate leverage.
SYK Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Stryker Corporation's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether SYK is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track SYK's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Stryker Corporation converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of SYK's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use SYK Financial Data
Investors use Stryker Corporation's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare SYK's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how SYK's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View SYK's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Stryker Corporation's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.SYK trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.